TRANS Government Research Act
The source supplies the latest action, but no lifecycle stage.
Latest action (20 Aug 2026): Referred to the House Committee on Energy and Commerce.
What this bill does
H.R. 10127, titled the "Terminating Radical Attempts to Negate Sex Through Government Research Act" or "TRANS Government Research Act," would bar the use of any federal funds to directly or indirectly conduct, support, or fund research studying the effects of gender-related medical treatment. The bill defines this "covered research" broadly to include studies of surgical procedures, hormone treatments, and puberty blockers used to address a person's perception that they are not their biological sex, as well as research on other methods of altering appearance to differ from one's sex. The bill also defines terms such as "male," "female," and "sex" based on biological reproductive function.
The bill would primarily affect federal agencies and federally funded researchers, such as those working through the National Institutes of Health or other government-supported programs, who study gender-related medical treatments including hormone therapy, puberty blockers, and related surgeries. Universities, hospitals, and research institutions receiving federal grants for such studies could lose funding eligibility for this specific area of research.
The bill was introduced on August 20, 2026, by Rep. Nancy Mace and referred to the House Committee on Energy and Commerce. It has not yet been voted on by the committee or the full House, and would need to pass both chambers of Congress and be signed by the President before becoming law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
20 Aug 2026
Referred to the House Committee on Energy and Commerce.
Common questions
- What does H.R. 10127 do?
- H.R. 10127, titled the "Terminating Radical Attempts to Negate Sex Through Government Research Act" or "TRANS Government Research Act," would bar the use of any federal funds to directly or indirectly conduct, support, or fund research studying the effects of gender-related medical treatment. The bill defines this "covered research" broadly to include studies of surgical procedures, hormone treatments, and puberty blockers used to address a person's perception that they are not their biological sex, as well as research on other methods of altering appearance to differ from one's sex. The bill also defines terms such as "male," "female," and "sex" based on biological reproductive function. The bill would primarily affect federal agencies and federally funded researchers, such as those working through the National Institutes of Health or other government-supported programs, who study gender-related medical treatments including hormone therapy, puberty blockers, and related surgeries. Universities, hospitals, and research institutions receiving federal grants for such studies could lose funding eligibility for this specific area of research. The bill was introduced on August 20, 2026, by Rep. Nancy Mace and referred to the House Committee on Energy and Commerce. It has not yet been voted on by the committee or the full House, and would need to pass both chambers of Congress and be signed by the President before becoming law.
- Has H.R. 10127 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 10127. Check the latest action and official source below.
- Who sponsored H.R. 10127?
- H.R. 10127 was sponsored by Rep. Mace, Nancy [R-SC-1] (R-SC), with 0 cosponsors.
- What's the latest action on H.R. 10127?
- Referred to the House Committee on Energy and Commerce. (20 Aug 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Access to Medical Supplies Act
Lower Premiums, Faster Payments Act
More bills from Rep. Mace, Nancy [R-SC-1]
PURGE Act
Clothing Microplastic Transparency Act of 2026
School Freedom Act of 2026
Speak Your Truth Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.